Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Panchaud

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
International Journal of Environmental Research and Public Health|May 14, 2022
Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional StudyEva Gerbier, Guillaume Favre, Fatima Tauqeer, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 21, 2021
Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic-A multinational cross-sectional studyMichael Ceulemans, Veerle Foulon, Elin Ngo, et al.
The Journal of Clinical Psychiatry|December 11, 2012
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary reportAdrienne Einarson, Kelly Smart, Thierry Vial, et al.
Clinical Epidemiology|June 21, 2018
Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression ScaleAngela Lupattelli, Michael J Twigg, Ksenia Zagorodnikova, et al.
Journal of Clinical Medicine|July 14, 2023
Evolution of National Guidelines on Medicines Used to Treat COVID-19 in Pregnancy in 2020-2022: A Scoping ReviewEmeline Maisonneuve, Odette de Bruin, Guillaume Favre, et al.
Revue Medicale Suisse|May 7, 2016
[SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio]Etienne Weisskopf, Céline J Fischer Fumeaux, Myriam Bickle Graz, et al.
Journal of Clinical Pharmacology|December 17, 2011
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective studyAlice Panchaud, Chantal Csajka, Paul Merlob, et al.
Obstetrics and Gynecology|December 5, 2024
Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum DisorderPer Damkier, Erika B Gram, Michael Ceulemans, et al.
Obstetrics and Gynecology|April 17, 2025
In ReplyPer Damkier, Erika B Gram, Michael Ceulemans, et al.
Journal of Clinical Psychopharmacology|April 2, 2015
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective studyUrsula Winterfeld, Gil Klinger, Alice Panchaud, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
International Journal of Environmental Research and Public Health|May 14, 2022
Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional StudyEva Gerbier, Guillaume Favre, Fatima Tauqeer, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 21, 2021
Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic-A multinational cross-sectional studyMichael Ceulemans, Veerle Foulon, Elin Ngo, et al.
The Journal of Clinical Psychiatry|December 11, 2012
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary reportAdrienne Einarson, Kelly Smart, Thierry Vial, et al.
Clinical Epidemiology|June 21, 2018
Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression ScaleAngela Lupattelli, Michael J Twigg, Ksenia Zagorodnikova, et al.
Journal of Clinical Medicine|July 14, 2023
Evolution of National Guidelines on Medicines Used to Treat COVID-19 in Pregnancy in 2020-2022: A Scoping ReviewEmeline Maisonneuve, Odette de Bruin, Guillaume Favre, et al.
Revue Medicale Suisse|May 7, 2016
[SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio]Etienne Weisskopf, Céline J Fischer Fumeaux, Myriam Bickle Graz, et al.
Journal of Clinical Pharmacology|December 17, 2011
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective studyAlice Panchaud, Chantal Csajka, Paul Merlob, et al.
Obstetrics and Gynecology|December 5, 2024
Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum DisorderPer Damkier, Erika B Gram, Michael Ceulemans, et al.
Obstetrics and Gynecology|April 17, 2025
In ReplyPer Damkier, Erika B Gram, Michael Ceulemans, et al.
Journal of Clinical Psychopharmacology|April 2, 2015
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective studyUrsula Winterfeld, Gil Klinger, Alice Panchaud, et al.
Pageof 14